Hypertensive
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity (NCT07469800) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-04-23 |
| Mechanisms of Refractory Hypertension (Carvedilol) (NCT02357004) | University of Alabama at Birmingham | 2015-02-01 |
| Evaluation of Target Organs Damage in Hypertensive Patients (NCT01055353) | AstraZeneca | 2010-01-01 |
Track Hypertensive automatically
Every clearance here is in the API, with alerts when new ones post.